Anas Bizanti

5PUBLICATIONS
11CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 28, 2026
Obinutuzumab Versus Rituximab for the Treatment of Primary Membranous Nephropathy: A Systematic Review and Meta-Analysis.

Andrew Lurie, Padideh Daneii, Sana Khan

|Mar 12, 2026
Effect of Preprocedural Desmopressin on Complications after Kidney Biopsy: A Systematic Review and Meta-Analysis.

Andrew Lurie, Idys Solis, Padideh Daneii

|Apr 12, 2025
Reply to Acerbo et al. Do Beta-Blockers Really Matter in Patients with Myocardial Infarction Without Left Ventricular Systolic Dysfunction? Comment on "Sabina et al. Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J. Clin. Med. 2025, 14, 150".

Michael Sabina, Jennifer Trube, Graciela Luna

|Jan 11, 2025
Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Michael Sabina, Shrinand Shah, Mason Grimm

|May 03, 2021
An Unusual Association between Neurofibromatosis Type 1 and Diffuse B Cell Lymphoma.

Anas Bizanti, Ariege Bizanti, Ahmad Al-Abdouh

Pageof 1

Frequent Collaborators

2 joint publications

Michael Sabina

2 joint publications

Andrew Lurie

1 joint publications

Ahmad Al-Abdouh

1 joint publications

Shrinand Shah